Cost Of Illness Pengobatan Pasien Cronic Kidney Disease dengan Hemodialisa di Instalasi Rawat Jalan RS Soerojo Magelang
Cost of Illness Treatment for Chronic Kidney Disease Patients with Hemodialysis in the Outpatient Installation of Soerojo Hospital, Magelang
DOI:
https://doi.org/10.30872/jsk.v7i2.1046Keywords:
Analisis Biaya, Biaya Medis, Chronic Kidney DiseaseAbstract
References
[1] M. Nisar et al., “The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review,” Cost Effectiveness and Resource Allocation, vol. 22, no. 1, p. 65, Sep. 2024, doi: 10.1186/s12962-024-00566-9.
[2] C. W. G. KDIGO, “KDIGO 2024 Clinical Practice Guideline for the Evaluastion and Management of Chronic Kideney Disease,” Kidney International, vol. 105, no. 4, p. A1, Apr. 2024, doi: 10.1016/S0085-2538(24)00110-8.
[3] N. M. Hustrini, “Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities,” Acta Medica Indonesiana, vol. 55, no. 1, pp. 1–1, Mar. 2023.
[4] S. Sari, Z. Suhada, and T. Triagustini, “Cost of illness pasien gagal ginjal kronis di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau,” Jurnal Ilmiah Farmasi, vol. 19, no. 2, pp. 113–125, Dec. 2023, doi: 10.20885/jif.vol19.iss2.art10.
[5] E. Sunariyanti, T. M. Andayani, D. Endarti, and D. A. Puspandari, “Cost Analysis of Chronic Kidney Disease Patients in Indonesia,” Clinicoecon Outcomes Res, vol. 15, pp. 621–629, 2023, doi: 10.2147/CEOR.S388547.
[6] Fauziah, D. Wahyono, and L. E. Budiarti, “Cost Of Illness Dari Chronic Kidney Disease Dengan Tindakan Hemodialisis,” Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), vol. 5, pp. 149–158, 2015.
[7] J. Mende, N. D. Kartikawati, A. Titami, and H. Mahmuda, “Principles Of Dose Adjustment In Patients With Chronic Kidney Failure,” Jurnal Farmasi Sains dan Praktis, pp. 115–126, 2025.
[8] I. Hadning, H. Hendrawan, and W. K. Rahayu, “Cost of illness of chronic kidney disease patients with hemodialysis in Yogyakarta Indonesia,” in AIP Conference Proceedings, AIP Publishing, 2024.
[9] A. R. Villanueva et al., “Cost-of-illness analysis of chronic kidney disease (CKD) management in the Philippines,” Journal of Medical Economics, vol. 28, no. 1, pp. 494–507, Dec. 2025, doi: 10.1080/13696998.2025.2481766.
[10] R. Andhika et al., “One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia,” Int J Nephrol Renovasc Dis, vol. 18, pp. 87–101, Mar. 2025, doi: 10.2147/IJNRD.S508012.
[11] R. Nindela, S. N. Prastowo, E. F. Zulissetiana, S. Marisdina, and S. S. F. Putri, “Impact of Age Initiation and Duration of Hemodialysis on Impaired Cognitive Function Experienced by Chronic Kidney Disease (CKD) Patients,” Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, vol. 18, no. 1, pp. 36–43, Jun. 2024, doi: 10.33533/jpm.v18i1.7830.
[12] M. Hecking et al., “Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study,” Kidney Int Rep, vol. 7, no. 3, pp. 410–423, Dec. 2021, doi: 10.1016/j.ekir.2021.11.018.
[13] N. D. Kartikawati, T. M. Andayani, and D. Endarti, “Gambaran dan Luaran Klinik Terapi Anemia Pada Pasien Chronic Kidney Disease Dengan Hemodialisis Di RS PKU Muhammadiyah Yogyakarta,” Majalah Farmaseutik, vol. 19, no. 1, pp. 148–154, 2023.
[14] S. R. Vaidya and N. R. Aeddula, Chronic Renal Failure. StatPearls Publishing, 2020. Accessed: Mar. 18, 2021. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK535404/
[15] D. T. Zainal, D. G. Tamtomo, and B. Murti, “Correlation between the Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis and Erythropoietin Stimulating Agent Therapy and Hemoglobin Levels,” Indonesian Journal of Medicine, vol. 9, no. 2, pp. 145-`155, Apr. 2024, doi: 10.26911/theijmed.2024.9.2.715.
[16] H. N. Murdeshwar and F. Anjum, “Hemodialysis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Sep. 02, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK563296/
[17] S. Tanaka, T. Nakano, H. Hiyamuta, K. Tsuruya, and T. Kitazono, “Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study,” J Atheroscler Thromb, vol. 29, no. 8, pp. 1249–1264, Aug. 2022, doi: 10.5551/jat.62900.
[18] C. MacRae, S. W. Mercer, B. Guthrie, and D. Henderson, “Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care,” Br J Gen Pract, vol. 71, no. 704, pp. e243–e249, Feb. 2021, doi: 10.3399/bjgp20X714125.
[19] C. Kyriakopoulos and V. Gupta, “Renal Failure Drug Dose Adjustments,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 28, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK560512/
[20] X. Liu, P. Chen, Y. Liu, X. Jia, and D. Xu, “Medication burden in patients with dialysis-dependent CKD: a systematic review,” Ren Fail, vol. 46, no. 1, p. 2353341, doi: 10.1080/0886022X.2024.2353341.
[21] H. Jyrkilä et al., “Comorbidity and Medication Trends in Chronic Kidney Disease and Incident Atrial Fibrillation: A Nationwide Cohort Study,” Nephron, vol. 148, no. 11–12, pp. 755–767, Jun. 2024, doi: 10.1159/000539603.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
How to Cite
Similar Articles
- Ilham Firdaus Rizky Perkasa , Victoria Yulita Fitriani, Arsyik Ibrahim, Aktivitas Imunoglobulin M (IgM) Ekstrak Buah Mengkudu (Morinda citrifolia L.) Terhadap Tikus Putih (Rattus norvegiens) , Jurnal Sains dan Kesehatan: Vol. 1 No. 6 (2016): J. Sains Kes.
- Oktaviany Triana, Fajar Prasetya, Hadi Kuncoro, Laode Rijai, Aktivitas Antijamur Ekstrak Daun Ketepeng Cina (Cassia alata L.) , Jurnal Sains dan Kesehatan: Vol. 1 No. 6 (2016): J. Sains Kes.
- Ratih Saputri, Tjitjik Tjahjandarie, Mulyadi Tanjung, Alkaloid Kuinolin dari Melicope denhamii dan Uji Aktivitas Antikankernya , Jurnal Sains dan Kesehatan: Vol. 1 No. 9 (2018): J. Sains Kes.
- Aji Yudha Wijaya, Muhammad Amir Masruhim, Hadi Kuncoro , Aktivitas Antiinflamasi Ekstrak Daun Tembelekan (Lantana camara Linn) Pada Tikus Putih (Rattus norvegicus) , Jurnal Sains dan Kesehatan: Vol. 1 No. 6 (2016): J. Sains Kes.
- Swandari Paramita, Yadi Yasir, Ibnu Sina, Analisis Bioautografi Kromatografi Lapis Tipis dan Aktivitas Antibakteri Ekstrak Etanol Bawang Tiwai (Eleutherine bulbosa (Mill.) Urb.) terhadap Methicillin-resistant Staphylococcus aureus (MRSA) , Jurnal Sains dan Kesehatan: Vol. 1 No. 9 (2018): J. Sains Kes.
- Nazmy Maulidha, Aditya Fridayanti, Muhammad Amir Masruhim, Uji Aktivitas Antioksidan Ekstrak Daun Sirih Hitam (Piper sp.) terhadap DPPH (1,1-diphenyl-2-picryl hydrazyl) , Jurnal Sains dan Kesehatan: Vol. 1 No. 1 (2015): J. Sains Kes.
- Nurul Handayani, Muhammad Faisal, Rolan Rusli, Kajian Interaksi Obat pada Pasien Gagal Ginjal Rawat Inap di RSUD Panglima Sebaya Tanah Grogot , Jurnal Sains dan Kesehatan: Vol. 5 No. 4 (2023): J. Sains Kes.
- Vitta Anzelia Triyana, Nydia Hanan, Musnar Munir, Profil Perawatan Karies Gigi pada Anak Usia 0-18 Tahun di Poli Gigi dan Mulut Rumah Sakit Umum Daerah Abdoel Wahab Sjahranie Periode 2018–2021 , Jurnal Sains dan Kesehatan: Vol. 5 No. 6 (2023): J. Sains Kes.
- Gusnia Meilin Gholam, Analisis Penambatan Molekuler Senyawa Mangiferin dari Mahkota Dewa (Phaleria macrocarpa) terhadap Sap 5 Candida albicans , Jurnal Sains dan Kesehatan: Vol. 5 No. 3 (2023): J. Sains Kes.
- Andi Rezki Khaerun Nissa, Arisanty Arisanty, Nurisyah Nurisyah, Difusi Polifenol dari Krim Ekstrak Daun Kelor (Moringa oleifera) dengan Peningkat Penetrasi Dimethyl Sulfoxide (DMSO) , Jurnal Sains dan Kesehatan: Vol. 5 No. 6 (2023): J. Sains Kes.
You may also start an advanced similarity search for this article.

